Opening book details…
Can I read Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Esophageal Cancer: Results and Prognostic Factors on EtoBox?
Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Esophageal Cancer: Results and Prognostic Factors by YAMAMOTO, TAKAYA; NIIBE, YUZURU; MATSUMOTO, YASUO; DEKURA, YASUHIRO; OH, RYOONG-JIN; YAMASHITA, HIDEOMI; KAKUHARA, HISAO; AOKI, MASAHIKO; JINGU, KEIICHI is a Medicine article available to read on EtoBox.
What is Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Esophageal Cancer: Results and Prognostic Factors about?
## Background/aim: The aim of this multi-center retrospective study was to investigate the results of stereotactic body radiotherapy (sbrt) for pulmonary oligometastases from esophageal cancer. ## Patients and methods: Oligometastases from the esophagus were identified from a dataset of a japanese survey. the kaplan-meier method and cox regression were applied to perform analyses. ## Results: A total of 114 patients with 132 pulmonary oligometastases were collected. the 3-year local control rate, freedom from further metastasis (fffm) rate and overall survival (os) rate were 70.2%, 25.3% and 37.5%, respectively. performance status (ps) (ps 1 vs. ps 0, p<0.01), disease-free interval (p=0.03) and history of local therapy for metastasis (p=0.01) had significant relationships with fffm and only ps was an independent prognostic factor for os (ps 1 vs. ps 0, p=0.02; ps 2-3 vs. ps 0, p=0.04). ## Conclusion: Sbrt for pulmonary oligometastases from esophageal cancer provided good local control and survival.
Who reads Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Esophageal Cancer: Results and Prognostic Factors?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- YAMAMOTO, TAKAYA; NIIBE, YUZURU; MATSUMOTO, YASUO; DEKURA, YASUHIRO; OH, RYOONG-JIN; YAMASHITA, HIDEOMI; KAKUHARA, HISAO; AOKI, MASAHIKO; JINGU, KEIICHI
- Publisher
- International Institute of Anticancer Research; Anticancer Research USA Inc. (ISSN 0250-7005)
- Published
- 2020
- Language
- EN
- Field
- Medicine (Health Sciences)